Objective : Hypertensive intracerebral hemorrhage is a potentially life-threatening neurological deficit with the highest morbidity and mortality. In recent years, neuroendoscopy has been used to treat intracerebral hemorrhages (ICHs). However, the choice of neuroendoscopic surgery or craniotomy for patients with ICHs is controversial. The objective of this meta-analysis was to assess the efficacy of neuroendoscopic surgery compared to craniotomy in patients with supratentorial hypertensive ICH.
INTRODUCTION
Hypertensive intracerebral hemorrhage (HICH) is a condition that can cause high mortality rate 7) and severe disabilities 22)23) . Management of primary intracerebral hemorrhage remains controversial. Previous studies have shown that neurosurgical treatment rather than conservative treatment is associated with better outcomes (P < 0.001) 17) for HICH. .
Therefore, the objective of this meta-analysis was to compare craniotomy and neuroendoscopic surgery to determine which one might be safer and more effective in promoting outcomes and reducing complications in patients with HICHs.
METHODS AND MATERIALS

Retrieval strategy
Published articles that compared efficacy and safety of neuroendoscopic surgery and craniotomy in patients with supratentorial HICH up to December 2017 were retrieved. Searchable databases included Pubmed,
Embase, and Cochrane library. The process was established to find all articles based on MeSH terms and keywords of "craniotomy", "neuroendoscopic surgery" and "hypertensive intracerebral hemorrhage".
No limitation was used during literature search. We identified full-text papers from reference materials for further evaluation.
Eligibility criteria
Articles that met the following inclusion criteria were included in this analysis: (1) studies that were designed as randomized controlled trials; (2) articles that enrolled hypertensive intracerebral hemorrhage patients; (3) trials that compared craniotomy to neuroendoscopic surgery; and (4) studies that provided data of perioperative morbidity or mortality. Studies that did not meet the above inclusion criteria were excluded from meta-analysis.
Quality assessment
Two investigators independently rated the quality of retrieved studies. Risk of bias items (ROBI) recommended by the Cochrane Handbook for Systematic
Reviews of Interventions were chosen.
Data extraction
Data were extracted by two authors independently.
Disagreement was revolved by consensus. From each eligible study, data of the following were extracted:
first author family name, publication year, study total number, mean age, hematoma volume (mL), and death number.
Ethical approval was waived because this study did not involve human participants or animals. Informed consent was not required because no human participant was involved in this study.
Statistical analysis
Meta-analysis was performed by pooling results of reported incidence of death and morbidity of the individual therapeutic modality. Results are expressed as appropriate ratio/difference for dichotomous outcomes based on available data. The I2 statistic test was performed to further examine statistical heterogeneity between trials 8) . Studies with an I2 ≥ 50%
were considered to have moderate and high heterogeneity while those with I2 < 50% were considered to have low heterogeneity 9) . Random-effect model was adopted if I2 >50%. Otherwise, fixed-effect model was chosen.
Statistical significance was considered when P value was less than 0.05. All meta-analyses were performed using Review Manager Version 5.3 software (Revman;
The Cochrane collaboration Oxford, United Kingdom).
Findings of our meta-analysis are shown in forest plots. The risk of bias was evaluated using Begg's test and Egger's test.
RESULTS
Overview of literature search and study characteristics
A total of 213 studies were initially found after primary selection. Based on inclusion criteria, 206 irrelevant citations were excluded after reviewing titles and abstracts. Finally, a total of three RCTs 5)6)27) were included in this meta-analysis (Fig. 1) . These eligible studies included 289 subjects who underwent neuroendoscopic evacuation of supratentorial HICH and craniotomy with removal of HICH ( . Pooled data showed that neuroendoscopic surgery had lower risk of complications than craniotomy (OR = 0.11, 95% CI: 0.06-0.20; P < 0.00001) (Fig. 3) .
DISCUSSION
Hypertensive intracerebral hemorrhage is a major health burden with the highest morbidity and mortality. In case of a massive hematoma, neurosurgical drainage is a crucial therapeutic option.
Endoscopic evacuation in comparison with traditional craniotomy has been investigated 5) . However, many questions regarding minimally invasive surgery remain unanswered. Historically, craniotomy has been used as an appropriate therapy to treat HICH 4) . A recent RCT has shown that early craniotomy surgery might reduce mortality of ICH patients 17) . Craniotomy also has some advantages such as good view and immediate removal of hematoma with improvement in local blood circulation 19) that could improve outcomes.
However, there is no more studies showing good results neither any improvement of the outcome in .
The shortcoming of craniotomy is that it increases operation time and the risk of infection. Therefore, it is necessary that a minimally invasive surgery causing minimal trauma to normal brain region during the process of removal of hematoma should replace craniotomy to treat HICH 13) .
During neuroendoscopic surgery as a minimally invasive procedure, a small burr hole is created and a 5 to 8-mm-diameter endoscope is inserted into the brain tissue 25) . This minimal invasive surgery is performed using an operation endoscope, which has benefit of keeping normal hemostasis of brain and little damage for the skull due to making small bony window compared to craniotomy. Neuroendoscopic surgery has been successfully applied for hematoma evacuation with many advantages 28) . Some scholars have emphasized that hemorrhage position, hemorrhage volume, and patient condition should be considered in the selection of surgical method 11)14) .
Appropriate operative route is the key to achieve successful treatment of HICH. As neuroendoscopic removal of HICH is preceded within the cavity, it is possible to perform minimally invasive interventions for brain tissues regardless whether these tissues are normal or surrounded by damaged region 27) .
Regarding the incidence of complications, we found that patients who had undergone neuroendoscopic 
CONCLUSION
Our results suggest that neuroendoscopic surgery can significantly reduce the rate of complications in patients with HICH compared to craniotomy, although it does not improve death outcome. When all data were analyzed, it became obvious that these two methods had their own advantages and shortcomings.
Each had its own indications. It is difficult to decide which one is better for HICH patients. Thus, it is essential to select individualized treatment for each patient. Eligible randomized clinical trials are needed to verify the efficacy of neuroendoscopic approach for HICH in the future.
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